Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by FacBineon Mar 18, 2020 3:37am
64 Views
Post# 30820142

RE:RE:RE:RE:RE:RE:We at StageZero Life Sciences want to assure

RE:RE:RE:RE:RE:RE:We at StageZero Life Sciences want to assure Try harder, CONTACT Information Page: https://www.stagezerolifesciences.com/corporate-hq.html
KPOIndustries wrote: FacBine, took your advice and called. The number was not in service. That's promising. As I mentioned I like to try and get answers where I can. When the company's phone isn't working, that's a major problem. But hey, call me a badger and throw "the handbook" around.
FacBine wrote: Tough mosquito , take your complaints here: Company Contacts: James R. Howard-Tripp Chairman & CEO jht@stagezerols.com Tel: 1-855-420-7140 Ext. 1 Rebecca Greco Investor Relations rgreco@stagezerols.com Tel: 1-855-420-7140 Ext. 1838
KPOIndustries wrote:

Listen FacBine, I've lost a f$ckload on this company over false promises. I'm just asking legitimate questions. Everyone here is so defensive on criticism, why? Because deep down you know it's risky and it smells like this isn't all adding up. We as investors have been promised a lot and all we've gotten in the last 6 months is news on more and more financing. No updates on Benalux, no updates on telehealth, underachieving financials. So why bul$hit anymore? Let's get truth and fact in here and stop pumping bull$hit up everyone's a$$. Where are the facts? Does anyone have anything new and factual about SZLS in the past 6 months?

 

FacBine wrote: @KPOIndustries, here's something for you to read: https://messageboardfools.com/bashers.htm

 

KPOIndustries wrote:

Has anyone been to the lab? Does it exist? Is Tripp in a closet with a beaker and that's deemed to be a "lab"? The Richmond Hill office is a virtual office, no mention about that eh?

 

FacBine wrote:
We at StageZero Life Sciences want to assure our clients and shareholders that we are monitoring the coronavirus (COVID-19) situation closely. Our lab is currently open, and we are enacting safety measures around COVID-19. We will continue to monitor the situation and respond as appropriate. Should any shareholders be concerned you may reach out to us via investorrelations@stagezerols.com. About StageZero Life Sciences, Ltd. StageZero Life Sciences is dedicated to the early detection of cancer and multiple disease states through whole blood. Aristotle, our next generation test, is a panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform which has been validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer, with further validation currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com. Company Contacts: James R. Howard-Tripp Chairman & CEO jht@stagezerols.com Tel: 1-855-420-7140 Ext. 1 Rebecca Greco Investor Relations rgreco@stagezerols.com Tel: 1-855-420-7140 Ext. 1838 More at: https://www.stagezerolifesciences.com/

 

 


 

 






Bullboard Posts